The Financial Burden of Opioid-Related Abuse among Surgical and Non-Surgical Patients in Florida: A Longitudinal Study.
United States
economic burden
hospital
non-surgical
opioid abuse
opioids
surgical
Journal
International journal of environmental research and public health
ISSN: 1660-4601
Titre abrégé: Int J Environ Res Public Health
Pays: Switzerland
ID NLM: 101238455
Informations de publication
Date de publication:
30 08 2021
30 08 2021
Historique:
received:
16
07
2021
revised:
24
08
2021
accepted:
27
08
2021
entrez:
10
9
2021
pubmed:
11
9
2021
medline:
28
10
2021
Statut:
epublish
Résumé
Florida is one of the eight states labeled as a high-burden opioid abuse state and is an epicenter for opioid use and misuse. The aim of our study was to measure multi-year total room charges and costs billed for opioid abuse-related events and to compare the costs of inpatient opioid abusers and non-opioid abusers for Florida hospitals from 2011 to 2017. We constructed a retrospective case-control longitudinal study design on inpatient administrative discharge data across 173 hospitals. Opioid abuse was defined using both ICD-9-CM and ICD-10-CM systems. We found a statistically significant association between opioid abuse diagnosis and total room charge. On average, opioid abuse status increased the room charges by 8.1%. We also noticed year-to-year variations in opioid abuse had a remarkable influence on hospital finances. We showed that since 2015, the differences significantly increased from 4-5% to 13-14% for both room charges and cost, which indicates the financial burden due to opioid abuse becoming more frequent. These findings are important to policymakers and hospital administrators because they provide crucial insight into Florida's opioid crisis and its economic burden on hospitals.
Identifiants
pubmed: 34501717
pii: ijerph18179127
doi: 10.3390/ijerph18179127
pmc: PMC8430612
pii:
doi:
Substances chimiques
Analgesics, Opioid
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Références
Am J Manag Care. 2019 Jul;25(13 Suppl):S243-S249
pubmed: 31361426
J Pain Palliat Care Pharmacother. 2013 Aug;27(3):206-13
pubmed: 23879214
JAMA. 2017 Oct 24;318(16):1539-1540
pubmed: 28832871
Health Econ. 2019 May;28(5):666-677
pubmed: 30864299
J Subst Abuse Treat. 2018 Sep;92:35-39
pubmed: 30032942
Fed Regist. ;81(219):79562-892
pubmed: 27906530
MMWR Morb Mortal Wkly Rep. 2016 Dec 30;65(50-51):1445-1452
pubmed: 28033313
J Manag Care Pharm. 2005 Jul-Aug;11(6):469-79
pubmed: 15998164
J Manag Care Spec Pharm. 2017 Apr;23(4):427-445
pubmed: 28345440
Anesthesiology. 2018 May;128(5):880-890
pubmed: 29470180
Med Care. 2017 Nov;55(11):918-923
pubmed: 28930890
Postgrad Med. 2014 Jul;126(4):53-8
pubmed: 25141243
Appl Health Econ Health Policy. 2014 Aug;12(4):435-46
pubmed: 24919646
JAMA Intern Med. 2015 Oct;175(10):1642-9
pubmed: 26280092
J Pain Palliat Care Pharmacother. 2010 Sep;24(3):251-8
pubmed: 20718646
Drug Alcohol Depend. 2002 Mar 1;66(1):45-50
pubmed: 11850135
JAMA Netw Open. 2019 Apr 5;2(4):e191827
pubmed: 30977846
Pain Pract. 2014 Mar;14(3):E116-25
pubmed: 24268019
MMWR Morb Mortal Wkly Rep. 2020 Mar 20;69(11):290-297
pubmed: 32191688
J Pain Palliat Care Pharmacother. 2010 Mar;24(1):5-18
pubmed: 20345194
Drug Alcohol Depend. 2015 May 1;150:63-8
pubmed: 25746236
JAMA. 2017 Mar 21;317(11):1117-1118
pubmed: 28241189
J Pain Palliat Care Pharmacother. 2015;29(4):388-400
pubmed: 26654413
JAMA Intern Med. 2020 May 1;180(5):753-759
pubmed: 32202609
Pain Med. 2011 Apr;12(4):657-67
pubmed: 21392250
JAMA. 2018 Jul 10;320(2):129-130
pubmed: 29896636
Biometrics. 1997 Sep;53(3):983-97
pubmed: 9333350
Drug Alcohol Depend. 2021 Jan 1;218:108350
pubmed: 33121867
Clin J Pain. 2006 Oct;22(8):667-76
pubmed: 16988561
MMWR Morb Mortal Wkly Rep. 2021 Apr 16;70(15):541-546
pubmed: 33857070
Am J Public Health. 2018 Feb;108(2):182-186
pubmed: 29267060